BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Benzel J, Fendrich V. Familial Pancreatic Cancer. Oncol Res Treat. 2018;41:611-618. [PMID: 30269130 DOI: 10.1159/000493473] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang Z, He D, Chen C, Liu X, Ke N. Vemurafenib Combined With Trametinib Significantly Benefits the Survival of a Patient With Stage IV Pancreatic Ductal Adenocarcinoma With BRAF V600E Mutation: A Case Report. Front Oncol 2021;11:801320. [PMID: 35145907 DOI: 10.3389/fonc.2021.801320] [Reference Citation Analysis]
2 Rocha FG. Landmark Series: Immunotherapy and Targeted Therapy for Pancreatic Cancer. Ann Surg Oncol 2021;28:1400-6. [PMID: 33386541 DOI: 10.1245/s10434-020-09367-9] [Reference Citation Analysis]
3 Stott MC, Oldfield L, Hale J, Costello E, Halloran CM. Recent advances in understanding pancreatic cancer. Fac Rev 2022;11:9. [PMID: 35509672 DOI: 10.12703/r/11-9] [Reference Citation Analysis]
4 Tan M, Brusgaard K, Gerdes AM, Mortensen MB, Detlefsen S, Schaffalitzky de Muckadell OB, Joergensen MT. Cohort profile and heritability assessment of familial pancreatic cancer: a nation-wide study. Scand J Gastroenterol 2021;56:965-71. [PMID: 34165379 DOI: 10.1080/00365521.2021.1937697] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sengul Samanci N, Çelik E, Bagcilar O, Tutar O, Samanci C, Velidedeoglu M, Yassa AE, Demirci NS, Demirelli FH. Use of volumetric CT scanning to predict tumor staging and survival in pancreatic cancer patients that are to be administered curative resection. J Surg Oncol 2021;123:1757-63. [PMID: 33684252 DOI: 10.1002/jso.26455] [Reference Citation Analysis]
6 Hoare O, Fraunhoffer N, Elkaoutari A, Gayet O, Bigonnet M, Roques J, Nicolle R, McGuckin C, Forraz N, Sohier E, Tonon L, Wajda P, Boyault S, Attignon V, Tabone-Eglinger S, Barbier S, Mignard C, Duchamp O, Iovanna J, Dusetti NJ. Exploring the Complementarity of Pancreatic Ductal Adenocarcinoma Preclinical Models. Cancers (Basel) 2021;13:2473. [PMID: 34069519 DOI: 10.3390/cancers13102473] [Reference Citation Analysis]
7 Eguchi H, Kobayashi S, Gotoh K, Noda T, Doki Y. Characteristics of early-onset pancreatic cancer and its association with familial pancreatic cancer and hereditary pancreatic cancer syndromes. Ann Gastroenterol Surg 2020;4:229-33. [PMID: 32490337 DOI: 10.1002/ags3.12326] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Yu J, Yang X, Wu H, Li J. Clinical Significance of Color Ultrasound, MRI, miR-21, and CA199 in the Diagnosis of Pancreatic Cancer. J Oncol 2021;2021:2380958. [PMID: 34367281 DOI: 10.1155/2021/2380958] [Reference Citation Analysis]
9 Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. The Lancet 2020;395:2008-20. [DOI: 10.1016/s0140-6736(20)30974-0] [Cited by in Crossref: 153] [Cited by in F6Publishing: 118] [Article Influence: 76.5] [Reference Citation Analysis]
10 Bagias G, Kanavidis P, Vailas M, Despotidis M, Sotiropoulou M, Katsaros I, Maroulis I, Filippou D, Schizas D. Surgical management of familial pancreatic cancer: a systematic review of the literature. ANZ J Surg 2022. [PMID: 35758214 DOI: 10.1111/ans.17834] [Reference Citation Analysis]
11 Ferreira RG, Narvaez LEM, Espíndola KMM, Rosario ACRS, Lima WGN, Monteiro MC. Can Nimesulide Nanoparticles Be a Therapeutic Strategy for the Inhibition of the KRAS/PTEN Signaling Pathway in Pancreatic Cancer? Front Oncol 2021;11:594917. [PMID: 34354940 DOI: 10.3389/fonc.2021.594917] [Reference Citation Analysis]
12 Peng X, Yang R, Song J, Wang X, Dong W. Calpain2 Upregulation Regulates EMT-Mediated Pancreatic Cancer Metastasis via the Wnt/β-Catenin Signaling Pathway. Front Med 2022;9:783592. [DOI: 10.3389/fmed.2022.783592] [Reference Citation Analysis]
13 Mortazavi M, Moosavi F, Martini M, Giovannetti E, Firuzi O. Prospects of targeting PI3K/AKT/mTOR pathway in pancreatic cancer. Crit Rev Oncol Hematol 2022;:103749. [PMID: 35728737 DOI: 10.1016/j.critrevonc.2022.103749] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Buchholz SM, Ammer-Herrmenau C, Ellenrieder V, Neesse A. [Diagnostics and clinical management of premalignant diseases of the pancreas]. Internist (Berl) 2022. [PMID: 35234978 DOI: 10.1007/s00108-022-01308-w] [Reference Citation Analysis]
15 Olakowski M, Bułdak Ł. Current status of inherited pancreatic cancer. Hered Cancer Clin Pract 2022;20:26. [PMID: 35761384 DOI: 10.1186/s13053-022-00224-2] [Reference Citation Analysis]
16 Su T, Wang T, Zhang N, Shen Y, Li W, Xing H, Yang M. Long non-coding RNAs in gastrointestinal cancers: implications for protein phosphorylation. Biochem Pharmacol 2022;:114907. [PMID: 35007523 DOI: 10.1016/j.bcp.2022.114907] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Bruno R, Sensi E, Lupi C, Giordano M, Bernardini L, Vivaldi C, Fornaro L, Vasile E, Campani D, Fontanini G. Feasibility of BRCA1/2 Testing of Formalin-Fixed and Paraffin-Embedded Pancreatic Tumor Samples: A Consecutive Clinical Series. Diagnostics (Basel) 2021;11:1046. [PMID: 34200245 DOI: 10.3390/diagnostics11061046] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Zeeshan MS, Ramzan Z. Current controversies and advances in the management of pancreatic adenocarcinoma. World J Gastrointest Oncol 2021;13:472-94. [PMID: 34163568 DOI: 10.4251/wjgo.v13.i6.472] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Watanabe T, Soeda S, Endo Y, Okabe C, Sato T, Kamo N, Ueda M, Kojima M, Furukawa S, Nishigori H, Takahashi T, Fujimori K. Rare Hereditary Gynecological Cancer Syndromes. Int J Mol Sci 2022;23:1563. [PMID: 35163487 DOI: 10.3390/ijms23031563] [Reference Citation Analysis]
20 Vietri MT, D’elia G, Caliendo G, Albanese L, Signoriello G, Napoli C, Molinari AM. Pancreatic Cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation. Genes 2022;13:321. [DOI: 10.3390/genes13020321] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Wieme G, Kral J, Rosseel T, Zemankova P, Parton B, Vocka M, Van Heetvelde M, Kleiblova P, Blaumeiser B, Soukupova J, van den Ende J, Nehasil P, Tejpar S, Borecka M, Gómez García EB, Blok MJ, Safarikova M, Kalousova M, Geboes K, De Putter R, Poppe B, De Leeneer K, Kleibl Z, Janatova M, Claes KBM. Prevalence of Germline Pathogenic Variants in Cancer Predisposing Genes in Czech and Belgian Pancreatic Cancer Patients. Cancers (Basel) 2021;13:4430. [PMID: 34503238 DOI: 10.3390/cancers13174430] [Reference Citation Analysis]
22 Debernardi S, O'Brien H, Algahmdi AS, Malats N, Stewart GD, Plješa-Ercegovac M, Costello E, Greenhalf W, Saad A, Roberts R, Ney A, Pereira SP, Kocher HM, Duffy S, Blyuss O, Crnogorac-Jurcevic T. A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case-control study. PLoS Med 2020;17:e1003489. [PMID: 33301466 DOI: 10.1371/journal.pmed.1003489] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
23 Vay C, Babaei S, Safi S, Dizdar L, Rehders A, Haeberle L, Roderburg C, Loosen SH, Esposito I, Knoefel WT, Krieg A. Clinicopathological and Prognostic Value of Survivin Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma. Cancers 2022;14:3494. [DOI: 10.3390/cancers14143494] [Reference Citation Analysis]
24 Kato S. Tumour-Agnostic Therapy for Pancreatic Cancer and Biliary Tract Cancer. Diagnostics (Basel) 2021;11:252. [PMID: 33562094 DOI: 10.3390/diagnostics11020252] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]